Kernreagenzien für die Erforschung von Infektionskrankheiten

Infectious diseases are caused by various pathogens, including viruses, bacteria,  fungi, or parasites. These diseases  can spread from person-to-person by direct contact,  water, foodborne illness, or aerosolization of infected particles in the environment and through insects (mosquitoes) and ticks.
In late 2019, the SARS-COV-2 pandemic posed a serious threat to human health and  social-economic development. Looking back to human history, several kinds of infectious diseases, such as smallpox, plague, and Spanish flu, all made huge impacts on human society. Until now, influenza virus, rabies virus, respiratory syncytial virus, human papillomavirus and many other infectious viruses are still constantly threatening the safety of our life. Therefore, now current scientific and medical industry is focusing to develop safe and effective vaccines and drugs to prevent and treat infectious diseases.
ACROBiosystems has accumulated mature technology and experience in viruses and  vaccines. Since the COVID-19 outbreak, we  continued to develop core reagents for other infectious virus research, vaccine, and therapeutic drug development based on its high-quality platform. We will continue to monitor the development of infectious diseases worldwide, aiming to provide core reagents for  accelerating the development and clinical trials of  vaccines and therapeutic drugs.

Viruses of Concern

Main Features

HEK293 expression: the protein structure is closer to the natural conformation;

High purity verified by SDS-PAGE and MALS;

High Bioactivity verified by antigen-antibody or antigen-receptor binding experiments;

High immunogenicity, which can induce higher antibody titers;

It can be used for drug screening and vaccine development.

Product List

RSV
influenza
VZV
MPXV
HIV
RABV
HSV
NiV
HeV
ZIKV
DENV
SFTSV
EBV
EBOV
Rotavirus
LCMV
Vaccinia Virus
HCMV
hMPV
JEV
HPV
MuV
HTNV
TBEV

Resources

Core Reagents for Infectious Disease Research
Solutions for Influenza Vaccines Development
Solutions for RSV vaccine and drug development
Solutions for Herpesviruses Vaccines Development
Developing Methods to Evaluate Active Ingredients in Influenza Vaccines and Quantify Vaccine Efficacy
Analytical Methods to Identify Structural Conformation of RSV Pre- and Post-fusion Proteins for Vaccine Development
  • Introduction
  • Viruses of Concern
  • Main Features
  • Product List
  • Resources